Skip to main content
SpringerLink
Log in

Access and Availability of Pharmaceuticals in International Health

  • Chapter
Managing Pharmaceuticals in International Health

Abstract

By the end of this chapter you should be able to:

  • Describe the global drug gap.

  • List reasons for inequalities in access to essential medicines.

  • Define accessibility, availability, acceptability and affordability in relation to medicines.

  • Describe four strategies for improving access to medicines.

  • Define neglected diseases and most neglected diseases.

  • List factors leading to diseases being neglected.

  • Describe three strategies for developing treatments for neglected diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Further Reading

  • Essential Drugs Monitor 28 (2000) Geneva: World Health Organization.

    Google Scholar 

  • Essential Drugs Monitor 29 (2000) Geneva: World Health Organization.

    Google Scholar 

  • “Fatal imbalance: The crisis in research and development for drugs for neglected diseases” (2001) MĂ©decins Sans Frontières Access to Essential Medicines Campaign and the Drugs for Neglected Diseases Working Group. Paris: MĂ©decins Sans Frontières.

    Google Scholar 

  • Trouiller, P., Olliaro, P., Torreele, E., Orbinski, J., Laing, R. and Ford, N. (2002) “Drug development for neglected diseases: a deficient market and a public-health policy failure”. Lancet 359: 2188–2194.

    Article  PubMed  Google Scholar 

  • Reich, M. (2000) “The global drug gap”, Science 287: March 1979.

    Google Scholar 

  • Sachs, J. et al. (2001) Macroeconomics and Health: Investing in Health for Economic Development. Geneva: World Health Organization.

    Google Scholar 

Download references

Authors
  1. Karin Wiedenmayer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Basel AG

About this chapter

Cite this chapter

Wiedenmayer, K. (2004). Access and Availability of Pharmaceuticals in International Health. In: Managing Pharmaceuticals in International Health. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-7913-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-7913-2_2

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-7643-6601-8

  • Online ISBN: 978-3-0348-7913-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation